KDM6B and pancreatic adenocarcinoma: In contrast, KDM6B knockdown promotes tumor sphere formation, increases hepatic metastasis and peritoneal dissemination in pancreatic adenocarcinoma, and enhances epithelial-mesenchymal transition and invasiveness in colon cancer cells [17, 18].